Anti-CD38/ ADPRC 1/ ADPRC1 monoclonal antibody

Anti-CD38/ ADPRC 1/ ADPRC1 antibody for FACS & in-vivo assay

Target products collectionGo to CD38/CD38 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T10877-Ab-1/ GM-Tg-hg-T10877-Ab-2Anti-Human CD38 monoclonal antibodyHuman
GM-Tg-rg-T10877-Ab-1/ GM-Tg-rg-T10877-Ab-2Anti-Rat CD38 monoclonal antibodyRat
GM-Tg-mg-T10877-Ab-1/ GM-Tg-mg-T10877-Ab-2Anti-Mouse CD38 monoclonal antibodyMouse
GM-Tg-cynog-T10877-Ab-1/ GM-Tg-cynog-T10877-Ab-2Anti-Cynomolgus/ Rhesus macaque CD38 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T10877-Ab-1/ GM-Tg-felg-T10877-Ab-2Anti-Feline CD38 monoclonal antibodyFeline
GM-Tg-cang-T10877-Ab-1/ GM-Tg-cang-T10877-Ab-2Anti-Canine CD38 monoclonal antibodyCanine
GM-Tg-bovg-T10877-Ab-1/ GM-Tg-bovg-T10877-Ab-2Anti-Bovine CD38 monoclonal antibodyBovine
GM-Tg-equg-T10877-Ab-1/ GM-Tg-equg-T10877-Ab-2Anti-Equine CD38 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T10877-Ab-1/ GM-Tg-hg-T10877-Ab-2; GM-Tg-rg-T10877-Ab-1/ GM-Tg-rg-T10877-Ab-2;
GM-Tg-mg-T10877-Ab-1/ GM-Tg-mg-T10877-Ab-2; GM-Tg-cynog-T10877-Ab-1/ GM-Tg-cynog-T10877-Ab-2;
GM-Tg-felg-T10877-Ab-1/ GM-Tg-felg-T10877-Ab-2; GM-Tg-cang-T10877-Ab-1/ GM-Tg-cang-T10877-Ab-2;
GM-Tg-bovg-T10877-Ab-1/ GM-Tg-bovg-T10877-Ab-2; GM-Tg-equg-T10877-Ab-1/ GM-Tg-equg-T10877-Ab-2
Products NameAnti-CD38 monoclonal antibody
Formatmab
Target NameCD38
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CD38 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-133Pre-Made Daratumumab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody
    BiosimilarGMP-Bios-ab-279Pre-Made Isatuximab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody
    BiosimilarGMP-Bios-ab-352Pre-Made Modakafusp biosimilar, Whole mAb Fusion: Anti-ADPRC therapeutic antibody
    BiosimilarGMP-Bios-ab-208Pre-Made Felzartamab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody
    BiosimilarGMP-Bios-ab-342Pre-Made Mezagitamab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody
    BiosimilarGMP-Bios-INN-917Pre-Made Modakafusp Alfa Biosimilar, Fusion Protein targeting CD38 fused with human IFNA2 (interferon alpha 2) *b (R46,H57) 24-188: Recombinant therapeutic protein targeting ADPRC 1/ADPRC1
    Target AntigenProducts DevelopingMulti-species CD38/ ADPRC 1/ ADPRC1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002021human CD38 Lentivirus particle
    ORF Viral VectorpGMLP002021human CD38 Lentivirus plasmid
    ORF Viral VectorpGMLPm000634mouse Cd38 Lentivirus plasmid
    ORF Viral VectorvGMLPm000634mouse Cd38 Lentivirus particle


    Target information

    Target IDGM-T10877
    Target NameCD38
    Gene ID952,12494,25668,714399,403756,101101308,327677,100068959
    Gene Symbol and SynonymsADPRC 1,ADPRC1,cADPR1,CD38,Cd38-rs1,I-19
    Uniprot AccessionP28907,Q64244
    Uniprot Entry NameCD38_HUMAN,CD38_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseCancer
    Gene EnsemblENSG00000004468
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: CD38, gene name: CD38, also named as ADPRC 1, ADPRC1. The protein encoded by this gene is a non-lineage-restricted, type II transmembrane glycoprotein that synthesizes and hydrolyzes cyclic adenosine 5'-diphosphate-ribose, an intracellular calcium ion mobilizing messenger. The release of soluble protein and the ability of membrane-bound protein to become internalized indicate both extracellular and intracellular functions for the protein. This protein has an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a C-terminal extracellular region with four N-glycosylation sites. Crystal structure analysis demonstrates that the functional molecule is a dimer, with the central portion containing the catalytic site. It is used as a prognostic marker for patients with chronic lymphocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.